Pharma, Pharmaceutics and Biotechnology Conference

Clinical trials and translational research form two inextricable elements of cutting-edge medical innovation: clinical trials and translational research, side by side, to fill the chasm between discovery and patient care.

The session will detail how innovative work emerges from the laboratory and makes its way into the clinic through the process of clinical trials transforming basic science into therapeutic breakthroughs.

Translational research, or ""bench to bedside,"" is the translation of scientific information generated from a laboratory-based work into new drugs, therapies, or clinical tools that can be applied to patients.

This session will note some of the highlights of translational research-from novel treatments for cancer to rapid vaccine development-through examples showing how collaboration between researchers and clinicians accelerates the pipeline in discovery-to-therapy. Clinical trials is the motor that drives this translation, as it forms the basis upon which these novel treatments born from preclinical research will be taken to test.

From early-phase safety and dosing studies to late-phase studies on efficacies in a heterogeneous population of patients, attendees will receive insight into the nature and objectives of clinical trials.

It will focus on how judiciously designed clinical studies are essential to really establish the impact of any new therapies for safety, efficacy, and benefits to patients. Interdisciplinary collaboration becomes an important component of this session in translational research.

The maturation of genomics and bioinformatics into personalized medicine has significantly accelerated precision therapies that are focused each on the particular medical necessity of each patient. Translational research based on patient feedback and input during the trial ensures that new treatments are not only scientifically sound but also practical for the clinical setting.

Participants will also learn the challenges of taking research into clinical practice: the regulatory burden, ethical issues, and the need for patient involvement in clinical studies.

The session will attempt to illustrate the strategies of those approaches in overcoming the barriers, including adaptive trial designs and the use of biomarkers for the selection of the most efficient patients for treatment.

Through case studies and expert presentations, the attendees will learn how clinical trials are evolving to stay abreast with rapid advancements of science to get more targeted and effective treatments to the marketplace faster.

Be it a researcher, a clinician, or a healthcare professional, this session will make one understand how translational research and clinical trials are changing the future of medicine.

By the end of the session, the audience will have a clear understanding of the critical role that translational research plays in the advancing care of patients, and they will practically learn how to structure, conduct, and navigate clinical trials to advance innovative therapies from the bench to the bedside.